Puma Biotech (PBYI) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY24 Revenue Guidance
Go back to Puma Biotech (PBYI) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY24 Revenue Guidance| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 9.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.60 | 52 Week High | $82.81 | |||
| Open | $9.60 | 52 Week Low | $19.74 | |||
| Day High | $9.60 | P/E | N/A | |||
| Day Low | $9.60 | EPS | $-2.16 | |||
| Volume | 2 | |||||
